Phase II, open, one-site, pilot Clinical trial for assessing the pharmacokinetic characteristics, safety and tolerability after conversion of the immuno-suppressive regimen with Advagraf to Envarsus in patients with stable pulmonary transplant.

Trial Profile

Phase II, open, one-site, pilot Clinical trial for assessing the pharmacokinetic characteristics, safety and tolerability after conversion of the immuno-suppressive regimen with Advagraf to Envarsus in patients with stable pulmonary transplant.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Sep 2017

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Lung transplant rejection
  • Focus Pharmacokinetics
  • Acronyms TX PULMONARY
  • Most Recent Events

    • 27 Sep 2017 Results presented at the 18th Congress of the European Society for Organ Transplantation
    • 13 May 2017 Status changed from recruiting to completed.
    • 28 Apr 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top